LYFCX Holdings Information

LYFCX is a mutual fund with a total of 63 individual holdings. The top holdings are Gilead Sciences stock at 7.21%, First American Treasury Obligations Fund at 6.52%, Vertex Pharmaceuticals at 5.71%, AstraZeneca at 5.28%, and Ionis Pharmaceuticals at 3.96%.

Total Holdings

Top 10 Percentage

44.91%

Asset Class

Equity

Fund Category

Health

Assets

40.72M

Forward PE Ratio

18.46

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	GILD	Gilead Sciences, Inc.	7.21%	21,761
2	FXFXX	First American Treasury Obligations Fund	6.52%	2,412,797
3	VRTX	Vertex Pharmaceuticals Incorporated	5.71%	4,663
4	AZN	AstraZeneca PLC	5.28%	21,243
5	IONS	Ionis Pharmaceuticals, Inc.	3.96%	18,523
6	INCY	Incyte Corporation	3.59%	13,471
7	INSM	Insmed Incorporated	3.57%	7,588
8	ARGX	argenx SE	3.24%	1,425
9	AXSM	Axsome Therapeutics, Inc.	3.00%	6,088
10	NBIX	Neurocrine Biosciences, Inc.	2.83%	7,383
11	ROIV	Roivant Sciences Ltd.	2.64%	45,076
12	AVDL	Avadel Pharmaceuticals PLC	2.19%	37,693
13	APGE	Apogee Therapeutics, Inc.	2.19%	10,751
14	EXAS	Exact Sciences Corporation	2.17%	7,901
15	PTGX	Protagonist Therapeutics, Inc.	2.02%	8,549
16	AMGN	Amgen Inc.	1.95%	2,202
17	ASND	Ascendis Pharma A/S	1.87%	3,238
18	ABBV	AbbVie Inc.	1.84%	2,979
19	SNY	Sanofi	1.78%	13,594
20	BIIB	Biogen Inc.	1.72%	3,627
21	JAZZ	Jazz Pharmaceuticals plc	1.55%	3,368
22	RYTM	Rhythm Pharmaceuticals, Inc.	1.46%	5,052
23	ALNY	Alnylam Pharmaceuticals, Inc.	1.39%	1,295
24	CPRX	Catalyst Pharmaceuticals, Inc.	1.39%	22,020
25	BNTX	BioNTech SE	1.37%	5,311

Showing 25 of 63 holdings

Subscribe to see the full list

Activate Now

As of Dec 31, 2025